top of page


Noviembre, Número 71

  • Preoperative plasma fibrinogen level and transfusion in cardiac surgery: a biphasic correlation

  • Outcomes Associated with 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients

  • Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery

  • Detection of hypofibrinogenemia during cardiac surgery: a comparison of resonance-based thrombelastography with the traditional Clauss method

Octubre, Número 70  

  • Four-Factor Prothrombin Complex Concentrate: An Indispensable Adjunct in Coagulopathy of Trauma Management - A Comparative Review of the Literature over 2 Decades

  • A Review of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?

  • Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients

  • Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes

Septiembre, Número 69  

  • Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

  • Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate

  • The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count

  • COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Julio, Número 68  

  • Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

  • Interventional Algorithm in Gastrointestinal Bleeding-An Expert Consensus Multimodal Approach Based on a Multidisciplinary Team

  • The effects of hemodilution on coagulation in term parturients: an in vitro study utilizing rotational thromboelastometry

Junio, mero 67  

  • The Use of 4F-PCC to Correct Direct Oral Anticoagulant-Induced Coagulopathy: An Observational Analysis

  • COVID-19 and its implications for thrombosis and anticoagulationç

  • Current Perspective on Fibrinogen Concentrate in Critical Bleeding

  • COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection

Mayo, Número 66  

  • Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

  • Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

  • ISTH interim guidance on recognition and management of coagulopathy in COVID-19

  • COVID-19 Coagulopathy in Caucasian patients

Abril, Número 65  

  • Propuesta de recomendaciones de manejo de fármacos anticoagulantes y antiagregantes en los pacientes graves con infección por COVID-19

  • Prominent Changes in Blood Coagulation of Patients With SARS-CoV-2 Infection

Especial COVID-19

  • Recursos ISTH

  • Recursos ESICM

  • Búsqueda bibliográfica en PubMed con los criterios de búsqueda

  • Comunicados de CSL

Marzo, Número 64  

  • Analysis of the hemostatic therapy in liver transplantation guided by rotational thromboelastometry or conventional laboratory tests

  • Utilization of 4-Factor Prothrombin Complex Concentrate for Reversal of Oral Factor Xa Inhibitor-Associated Acute Major Bleeding: A Case Series

  • Trials and Tribulations of Viscoelastic-Based Determination of Fibrinogen Concentration

  • Traumatic-Induced Coagulopathy as a Systems Failure: A New Window into Hemostasisibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death

Febrero, Número 63  

  • Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death

  • Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal

  • Pediatric non-red cell blood product transfusion practices: what's the evidence to guide transfusion of the 'yellow' blood products?

  • A retrospective register study comparing fibrinogen treated trauma patients with an injury severity score matched control group

Enero, Número 62  

  • Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood transfusion

  • Reversal of warfarin anticoagulation in geriatric traumatic brain injury due to ground-level falls

  • The prophylactic use of fibrinogen concentrate in high-risk cardiac surgery

  • Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants


bottom of page